Kymriah (tisagenlecleucel)

tisagenlecleucel · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kymriah (tisagenlecleucel), covering 2025-06-06 to 2025-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies